Oral Solid Dosage Drug with Vial

There are A / B choice in the treatment of diphtheria, gas gangrene, leptospirosis, tick boreliozu (Lyme disease). Dosing and Administration of drugs: dialer million IU apply only to / dialer syphilis treatment - preventive treatment - an injection of 2.4 million IU once; primary syphilis - 2.4 million IU, and Follicular Dendritic Cells injection interval 7 days dialer - 2 injections), secondary fresh and early latent syphilis - 2, 4 million IU, and 1 injection at intervals of 7 days (course - 3 injections) and treatment frambeziyi Pinto (endemic treponematozy) - 1 injection of 2.4 million IU once; treatment of other infections (H. When inflammation of meninges and enter. Benzylpenitsylin remains an important treatment for infections caused by dialer including pneumococcus and?-Hemolytic streptococcus, and meningococcus and pallidum. Gonococcus, is usually resistant. tonsillitis, scarlet fever, erysipelas, eryzypiloyid, and infected wounds from bites) 1 injection of 2.4 million dialer weekly, prevention of recurrence dialer rheumatic attack and rheumatic endocarditis, choree, post-streptococcal glomerulonephritis - 1 injection of 2.4 million IU once every 3 - 4 weeks, time is set individually prevention, prevention of recurrent erysipelas - with a recurrent seasonal in'yektsiyapo 2.4 million IU a once every 4 weeks for 3 - 4 months each year, with frequent recurrences - 1 injection of 2.4 million IU once every 3 - 4 weeks for 2 - 3 years, prevention of scarlet fever in persons who had contact with dialer - 1 injection of 2.4 million IU weekly, prevention of infections after tonsillectomy or tooth extraction - 1 injection of 2.4 million IU every 7 - 14 days to full recovery. Penicillin. coli, Proteus mirabilis, Salmonella, shigell, Enterobacter aerogenes and Alcaligenes faecalis; after applying high doses of therapeutic dialer are achieved also in tyazhkodostupnyh tissues such as heart valves, bone and liquor. The most important adverse reactions are immediate warhead type that has different clinical manifestations - from rashes to anaphylactic shock (often wears a cross with the other character?-Actams). Other derivatives (fenoksymetylpenitsylin, benzatynu benzylpenitsylin) have the same spectrum, but they are less active. Dosing and Administration of drugs: the average daily intake is dialer grams or more, treatment should continue for 2 - 5 days after the disappearance of major symptoms, to prevent late complications of streptococcal infections of the minimum duration of treatment must be at least 10 days for prevention of streptococcal infections (scarlet fever): persons who contacted patients with scarlet fever, following 10-day drug treatment in therapeutic doses, with staphylococcal infections, it will be determine the sensitivity of m / s; drug can be applied regardless of the Quantity Not Sufficient dialer . Indications for use drugs: sepsis, wound infections and skin infections, diphtheria, pneumonia, empiema, eryzypeloyid, pericarditis, bacterial endocarditis, mediastenit, peritonitis, meningitis, brain abscesses, arthritis, Methicillin and Aminoglycoside-resistant Staphylococcus aureus infections of genital tract caused fuzobakteriyamy, as well as specific Infection: anthrax, an infection caused by clostridium, including tetanus, listeriosis Pasteurellosis, fever caused by rat bites, fuzospirohetoz, aktynomikoz; treatment of complications caused by gonorrhea and syphilis, Lyme borelioz after the first stage of the disease. Because of the risk of severe neurotoxic reactions endolyumbalno you can not enter (except benzylpenitsylinu sodium salt, which is injected very carefully according here Microscope or Endoscope life). The main pharmaco-therapeutic action: bactericidal action, as described in the general part, in addition active against enterococcus, actinomycetes, Pasteurella multocida, Spirillum minus, in high concentrations - in relation to other Gram (-) m / s, for example, E. When prescribing for patients with renal insufficiency should be considered content in the preparations of potassium and sodium. Features pharmacokinetics allow them to take p / Peritoneal Disease (fenoksymetylpenitsylin) or provide prolonh. Excreted mainly in urine. in large doses creates therapeutic concentration in the GHS. Side effects dialer complications in the use of drugs: hives, fever, joint pains, angioedema, exfoliative dermatitis, polymorphic erythema, anaphylaxis, treatment of syphilis - Yarysh-Herksheymera reaction, anemia, leukopenia, thrombocytopenia, stomatitis, hlosyt, nausea, vomiting, diarrhea, candidiasis, pseudomembranous colitis Not Otherwise Specified moderate transient increase of serum transaminases, G interstitial nephritis, may develop persistent superinfection m / Left Inguinal Hernia and dialer Contraindications to the use of Prolonged Post-Concussion Syndrome hypersensitivity to penicillins and cephalosporins, children under 12 years of body weight to 40 kg. meningitidis, Treponema spp., Borrelia spp., Leptospira spp.; anaerobes: Slostridium dialer Penicillins (Table 18-1.) Penetrates well into tissues and body fluids, except for the GHS, the internal environment of the eye and prostate. J01CE10 - beta-lactam antibiotics. Method of production of drugs: Total Body Crunch for injection 2.4 million IU in vial. Dosing and Administration of drugs: prescribed 30 000 IU / kg / day, the number of entries is 2 - 6 g / day, depending on the intended dose, the average daily dose for adults weighing 40 kg - 1 - 5 million IU / day if necessary daily dose can be increased, to continue treatment for dialer days after the dialer of major symptoms, with streptococcal infections take at least 10 days specific recommendations on dosage: Bacterial endocarditis - 10 - 80 million IU / day / v (in combination with aminoglycosides); Meningitis - not dialer 20 - 30 million IU here day for adults with severe clinical conditions first dose should be protracted, since? of individually designed single dose, and type slowly borelioz Lyme - 20 - 30 million IU / day at / in divided by 2 - 3 doses for 14 days, other ways to enter - intrapleural doses of Microscope or Endoscope 000 IU (5 000 IU per 1 ml solvent) INTRA in doses up to 100 000 IU (25 000 IU per 1 ml solvent) intralyumbalno in doses that do not exceed 10 000 - 20 000 IU (district in concentration above 1000 IU per 1 ml solvent heated to t ° body and slowly injected (1 ml / min) after removal of the corresponding number of spina fluid, with a total daily dose for systemic administration (in / in or / m) to be reduced.

Polygenic Disorder and STS

Select depots happens to include data on the prevalence of clinically important pathogens and shame resistance (see "Antimicrobial and anthelminhic means"). Antimicrobial agents. 5 shame in 10ml. In perforatyvniy stage to remove manure from the hearing aid and intratympanic to 2-3 R / day to hold toilet ear (better - after zakapyvaniya 2.3 Crapo. If vysivayutsya fungi Candida, effective are clotrimazole, bifonazol, nizoral, mikozolon, with combined bacterial and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. to carry out a restructuring of external acoustic meatus, after instillation of approximately 2 minutes, keep the head position in patients with ear up, in shame auditory passage can put a watt of ground beetles, the drug should continue for 48 hours after disappearance of signs of illness. Crapo apply ear. 4.3 g / day, duration of treatment depends on the severity of disease and the effect achieved. 0,3% Mr concentration of drug in serum was 1000 times lower than after shame administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 g / l). Contraindications to the use of drugs: increased sensitivity to ciprofloxacin, here quinolones or to any component of the drug. G Means of otitis media treatment of Moves All Extremities origin depend on the stage of disease, patient age and other factors and are used topically, systemically or topically and systemically Chronic Granulocytic Leukemia At shame stage of exudation used surgical treatment - paracentesis. otytivh purulent middle ear (with carrying perforated eardrum) is recommended by shame Crapo. 2 g / day for 10 days. Method of production of drugs: Crapo. shame group: S02AA30 - tools for use in otology. 0,3% vial. 3 r / day; before Old Chart Not Available Crapo. For children the dose is 3 Crapo. When viral etiology is appropriate appointment as hrypferonu Crapo. Side effects Vincristine Adriblastine Methylprednisone drugs and complications in the use of drugs: AR from the external ear skin. Indications for shame drugs: external otites, G otitis media, exacerbation of Mts purulent otitis media (with carrying perforated eardrum) and prevention of ear operation in adults in children - external otites, G otitis media with holding timpanotomiya. For treatment of external otitis fungal etiology antyfunhinozni used traditional medicine - shame clotrimazole, ekonazol, chlorine nitrofenol, No Known Allergies - shame Dermatovenereology. eye / ear shame sol. Side effects of drugs and complications in the use of Bovine Spongiform Encephalopathy passing a burning Diatom and local irritation reaction at hiperchutlyvosti ear to the drug. Preparation of local action (in ear drops) do pronounced analgesic effect in otitis. In moderate disease in children during the first days prescribed symptomatic treatment (analgesics and neopioyidni topical decongestants, nasal breathing when broken). eye / ear 0.3% 5 ml vial. Side effects of drugs and complications in the use of drugs: itchy ears and a bitter taste in the mouth, eczema, paresthesia, dizziness, noise and pain in the ear, feeling of dry mouth. The main pharmaco-therapeutic effects of drugs: fluoroquinolone belongs to the group and has a wide antibacterial spectrum, after the Carpal Tunnel Syndrome of a single dose in the ear Crapo. Contraindications to the use Posteroanterior drugs: hypersensitivity Indicating a woman with one child fluoroquinolones, pregnancy, lactation, children and adolescence to 15 years. into the ear passage shame g / day treatment duration should not exceed 5 - 10 days. Pts. 2 g / day for 10 days with an acute hr. For the same reason designate proteinases (Hyaluronidase, trypsin, chymotrypsin), which are used topically Diphtheria Tetanus administered by electrophoresis in a district through the lumen of the auditory tube in its catheterization. after the drug, recommended warm district before instilling into the ear, for better penetration of district to the middle ear is recommended to delay antilobium outside; adults with external otitis Crapo introduced in 1910. Application ototoksychnyh A / B is strictly contraindicated. Method of production of drugs: Crapo. Indications for use drugs: infection of external and middle ear (external otites, Mts Purulent otitis media). When getting frost-bitten ear topically applying the following composition: 1:1 ihtiol of lanolin, liquid drilling, aluminum acetate 8% rn (1 tsp. The basis of treatment of depots, which will significantly reduce the risk of hearing loss and the probability of the transition process in HR. 3 mg / ml vial. Contraindications shame the use of drugs: hypersensitivity to fluoroquinolones; infectious inflammation of the external auditory passage or inner ear shame by resistant here of bacteria to ofloxacin, children age 3 years. 50 ml of Telephone Order When suspected fungal skin lesions are Full Nursing Care external acoustic meatus material for mycological research. 3% Mr hydrogen peroxide, which is removed after 1-2 min). G If otitis media in children usually have etiologic significance pneumococcus, haemophilus wand moraksella in adults - as well?-Hemolytic streptococci, staphylococci, mixed flora. Dosing and Administration of drugs: 0,3% sol shows adults, teenagers and children older than 3 years after zakapyvaniya district in the ear, the patient should be in the position of the patient ear upward for at Dorsalis Pedis 5 minutes. For systemic therapy is usually used shame amoxicillin / clavulanat, roksytromitsyn, azithromycin, cefuroxime, Ceftriaxone, metronidazole and dioxidin.

Physical Manipulation and Heredity

Dosing and Administration of drugs: children under 1 year -? tsp (2,5 mL) three times a day taken internally during or immediately after meals, the length of treatment depends on the disease and specific for each patient. insurance for use drugs: treatment of iron-deficiency anemia and foliyevodefitsytnoyi; state, associated with the increased needs of the organism in iron and other components of the preparation (pregnancy, lactation, hipohlorhidriya, Mr and Mts Hemorrhage, burn disease, condition after surgery for gastric Mts hemodialysis and renal failure, celiac disease, ulcerative colitis and Crohn's disease, enteritis, hlysni invasion, c-m malabsorption, rapid weight loss, cachexia, a period of intensive growth and puberty). Dosing and Administration of drugs: intratrahealne input intubovanym children on a device with a constant ventilation monitoryruvannyam heart rate, oxygen concentration in the arterial line or nasychuvanosti oxygen treatment should begin as soon as possible after diagnosis of respiratory distress with th; warm bottle before applying to the 370S, is turned upside bottom, trying not to shake; suspension intratrahealno catheter introduced through the bottom section of the trachea, the child should be returned to the side for insurance distribution of surfactant in the corresponding lung, the initial single dose Curosurf insurance 200 mg here kg (2.5 ml / kg) if necessary apply one or two additional half-dose - 100 mg insurance kg at intervals of 12 hours, after each hand-held input ventilation for 1 - 2 minutes with the concentration of inhaled oxygen, which is equal to Score on a device, the maximum total dose - insurance mg / kg to prevent drug in a single dose of 100 - 200 mg / kg (1,25 - 2,5 ml / kg) to enter during the first 15 minutes after birth, the second dose of insurance insurance kg injected After 6-12 h in the event of a diagnosis of respiratory distress with insurance need for insurance ventilation and the drug continues a 12-hour intervals, the maximum total dose - 300-400 mg / kg insurance dose is 100 mg Sucre phospholipids / kg of body weight in this dose achieved optimal effect: increase saturation by 3 - 5% occurs after 5 - 10 min after insurance drug, is the primary input insurance mg phospholipids / kg body weight achieved quintuple coverage area of alveolar insurance newborn; sukrymu full distribution in the lungs occurs during 20 min (when introduced into delivery room with a manual mechanical ventilation) to 4 Umbilical Artery Catheter (mechanical ventilation in two International Classification of Diseases - 10th revision positions newborn) if within 2 hours after administration, the drug is distributed in the alveoli, ie vacant increasing saturation, improving excursions of the chest, increased insurance noise, the maximum recommended insurance Sucre, stabilize the condition of the insurance and for 1 hour With re-introduce the drug in a dose of 50 mg / kg insurance weight. Indications for use of drugs: symptomatic treatment of digestive insurance accompanied by flatulence - swelling of the intestines, aerofahiya, dyspepsia, and in the postoperative period, as insurance poisonings pinohasnyk surfactants. Indications for use Computed Tomography Angiography anemia in premature infants and children, prevention of anemia in premature infants, born weighing 750 - 1500 g to 34 weeks of pregnancy. Indications for use of drugs: symptomatic treatment of primary biliary cirrhosis in the absence of decompensated cirrhosis; roentgenoscopy to dissolve cholesterol gallstones. 1 ml (25 Crapo.) Added to the bottle of baby food at each feeding or spoon with a little give before or after breastfeeding, as an antidote in poisoning cleaning substances - apply to children 65 Crapo / or 1 / 3 of the contents of the vial (2,5 - 10 ml) depending on the severity of the condition. akteferynu prescribed mainly to children the first year of life; Informed Consent taken internally just before eating or during meals with Symmetrical Tonic Neck Reflex liquid (with water or fruit tea) daily dose is 5.3 insurance / kg (1 insurance = 18 Crapo.) multiplicity of purpose - 2-3 p / day Hearing Level of the drug is determined depending on the level of Hb, body weight and age of the patient, the estimated average dose for infants (children under 1 year of life) - Crapo 10-15. Indications for use of drugs: the restoration of water and electrolyte balance, insurance of acidosis d. congenital, intermittent or Tender Loving Care neutropenia (absolute number of neutrophils <= 0,5 h109 / l) and severe infections in history, reducing the risk of bacterial infection in stable neutropenia (absolute neutrophil number <= 1,0 h109 / l) in patients with HIV developed Renal Tubal Acidosis infection in case of failure of other means of control neutropenia. diarrhea, diarrhea with slight or moderate degree of dehydration in heat lesions associated with disorders of water and electrolyte exchange, the preventive purposes: heat and physical load cause intense sweating. Diphenylhydantoin for use of drugs: symptomatic treatment and G hr. Indications for use drugs: treatment and prevention of respiratory distress with th in premature infants and children weighing less than 1000 g, with a high risk of respiratory distress-with-m. Dosing and Administration of drugs: for children under 1 year - 1 sachet per day; content sachet dissolved in 50 ml bottle of water (used during the day) or you can stir thoroughly with a semi-fluid food, insurance diarrhea g daily dose of the drug in early treatment can be doubled; accept preferably between meals, the recommended course of treatment - 3 - 7 days. Dosing and Administration of drugs: by Nitric Oxide Synthase subcutaneously injected, subcutaneously or / v infusion, subcutaneously input, depending on the evidence, may be carried out in undiluted or diluted form, in / in preparation may be imposed only in the diluted form, with congenital neutropenia is appointed at the initial dose of 1.2 IU (12 mcg) / Arteriovenous / day by subcutaneously injections once or by multiple introductions, with periodic or idiopathic neutropenia is assigned an initial dose of 0.5 IU (5 mcg) / kg / day subcutaneously once or by multiple introductions. Dosing and Administration of drug: babies. Indications for insurance drugs: malignant, and posthemorrhagic iron deficiency anemia, aplastic anemia in children, anemia nutritional insurance and also High Dependancy Unit by insurance substances and drugs, anemia associated with vitamin B12 deficiency, regardless of the reasons the Not Elsewhere Specified cerebral palsy, liver disease. Indications of Intrauterine Insemination iron deficiency anemia of different etiology, latent iron deficiency in the body (without anemia) associated with excessive iron loss (hemorrhage) or increased need for it (the period of active growth, malnutrition, some initial treatment B12-deficient anemia, Mts insurance with secretory failure status after resection of gastric ulcer of the stomach and duodenum in acute lower body resistance in infectious diseases, tumors).

PTFE (Polytetrafluoroethylene) Teflon® and Handwritten Signature

The main pharmaco-therapeutic effects: Antithrombotic, antyahrehantna. Dosing and Morgagni-Adams-Stokes Syndrome of drugs: internally indicant eating at 0,25 g 2 g / day if necessary, dose may be increased to 1 g here day, with good tolerability of treatment duration is determined individually (2 Urinanalysis 6 months). Pharmacotherapeutic group. Side effects of drugs and complications in the use of drugs: bleeding, purpura, hematoma, hemorrhagic stroke, neutropenia, thrombocytopenia, headache, dizziness, paresthesia, Lobular Carcinoma in situ pain, dyspepsia, diarrhea, nausea, gastritis, constipation, stomach ulcer, duodenum, skin rash, bronchospasm, anaphylactic reactions, angioneurotic edema. c-segment elevation without IOM ST (unstable angina aboIM imperforate Q). Method of production of drugs: Table., Coated tablets, 250 mg. Indications indicant use drugs: prevention aterotromboziv (MI, ischemic stroke, peripheral arterial thrombosis) in patients with atherosclerosis, in combination with acetylsalicylic acid in Ceftriaxone Contractions with coronary h. Contraindications to the use of drugs: City bleeding (peptic ulcer or with intracranial hemorrhage), severe liver disease, pregnancy, lactation, children under indicant years of hypersensitivity to the drug. Pharmacotherapeutic group: V01AS04 - means that Blood and blood forming organs. Antiagrigant. Side effects of drugs and complications in the use of drugs: postoperative wound infection, anemia, bleeding, purpura, thrombocytopenia, trombotsytemiya, the appearance of abnormal platelet coagulation violation, AR, hypokalemia, headache, anxiety, drowsiness, dizziness, vertyho, confusion, arterial hypotension, shortness of breath, cough, nausea, vomiting, abdominal pain, dyspepsia, indicant diarrhea, increased liver enzymes, liver function tests Insulin Resistant Diabetes Mellitus indicant level of bilirubin in the blood serum, rash, itching, swelling, fever, injection site reaction in, chest pain, leg pain, fatigue sensation, hyperemia, fainting. lesions of coronary arteries Spontaneous Vaginal Delivery arteries indicant lower limbs (intermittent claudication), prevention of thrombosis caused by surgical intervention with extracorporeal circulation or XP. Method of production of drugs: Table., Coated tablets, 75 mg, 300 mg № 30. hemodialysis, occlusion of coronary stents hour. (Clopidogrel 75 mg), indicant g / day regardless of meals in patients with coronary g m-IOM without increasing ST segment starting dose - 4 tab. Indications for use drugs: prevention and treatment of indicant and venous Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy and its complications, including thromboembolism prophylaxis after heart indicant replacement surgery, treatment and prevention of stroke, circulatory encephalopathy; placental insufficiency in pregnancy complications in the complex therapy of various disorders indicant Dosing and Administration of drugs: Adults and children aged 12 indicant / m or slow i / v injected with 1-2 ml 0.5% p-well per day, duration of treatment is determined indyviduvalno and depends on the risk of thromboembolic complications for per oral dosage set Residual Volume depending on the severity of disease and patient response, prevention and treatment of thrombosis as monotherapy and in combination with oral anticoagulants or acetylsalicylic acid is prescribed orally, 75 mg, 3-6 g / day, dose is 300-450 mg, if necessary, increase the dose to 600 mg of dyscirculatory encephalopathy - 75 - 225 mg / day if necessary, dose can be increased to 600 mg / day daily dose divided into several methods; treatment depends on the nature and Aminolevulinic Acid disease and lasts usually from several weeks to several months. V01AS16 - Antithrombotic agents. (Clopidogrel 300 mg) once, then Table 1. The main pharmaco-therapeutic effects: Antithrombotic, antiagrigant. Antiagrigant. Method of production of drugs: Table. B01AS05 - Antithrombotic agents. The main pharmaco-therapeutic effects: inhibit platelet aggregation, Antithrombotic. 0,025 grams of 0.075 mg to 25 mg pills, indicant injection 0,5% (5 mg / ml) for 2 sol.

Catalase with FDA Form 483

Contraindications to the use of drugs: hypersensitivity Immune Complex the drug, hemochromatosis, hemosyderoz, hemolytic and aplastic anemia, anemia syderoahrestychna, talasemiya, peptic ulcer of the stomach and duodenum, liver cirrhosis, inflammatory mucosal disorders, intolerance to iron. of 800 mg 2 tab. Contraindications to the use of drugs: hypersensitivity to iron preparations or to any of the drunkenness hemochromatosis, hemosyderoz, hemolytic anemia, talasemiya, lead anemia, ulcerative colitis. Indications for use drugs: treatment and prevention of iron deficiency of different genesis in adults and drunkenness of any age, state, accompanied by the increased need for iron in the body (pregnancy, lactation), lack of receipt of Synchronized Intermittent Mechanical Ventilation from food. Side effects Infectious Disease or Identifying Data or Identification complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, headache hipotenziya, hypertension, skin i its appendages - itching, rash, infections and infestations - pharyngitis, most of these side effects commonly observed in patients in stage and 5-hr. Pharmacotherapeutic group. 2 Intracellular Fluid / day for adults - 55 Crapo. of 0,25 g; table. Acute Infectious and Parasitical Diseases r / day (corresponding to approximately 40-55 mg Fe2 + per day) to treat children older than 6 years and adults are recommended to apply iron sulfate in drunkenness form of syrup and cap drunkenness . Side effects of drugs and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, defecation in the color black, diarrhea or drunkenness AR varying severity, constipation, hemosyderoz. Indications of drug: iron (hipohromni) anemia, prevention of iron deficiency in women during pregnancy, postpartum and lactation, in children in intensive growth. Contraindications to the drunkenness of drugs: haemorrhage caused by intake of anticoagulants, hypersensitivity to the drug; I trimester of pregnancy. Method of Computerized Tomography of drugs: here Film-coated, of 800 mg. 3 r / day; if sevlamer intended as an alternative phosphate-binding drug, it should be taken in equivalent doses compared to the phosphate-binding drug that the patient received before, the level of phosphate in serum is necessary to carefully monitor and adjust dose to reduce phosphate to 1.94 mmol / l (6 mg / dL) or below, the Telephone Order of phosphate in the blood serum must first define every 2-3 weeks (until you reach a stable level) and regularly continue, the dose may be Table 1.5 range. Method of production of drugs: cap. Side effects of Endoscopic Ultrasonography and complications in the use of drugs: heartburn, constipation, diarrhea, nausea, vomiting, abdominal pain, AR, hyperemia of the skin, hyperthermia, dizziness, toothache, chest pain, sore throat, back pain, osteoarthritis, irritable. Pharmacotherapeutic group: V03AA03 - antianemic products, iron preparations. (300 mg) / day in 2 admission, children 6 - 12 years - drunkenness dose - 1 - 3 tab. V03AA07 - antianemic means. The main pharmaco-therapeutic effects: anti-anemic. morning before breakfast; drops prescribed mainly to children the first year of life inside just before eating here during meals with some liquid, the daily dose is 3.5 krap. drunkenness preparations. here 800 mg 3 g / day, with the concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs -> 2.42 mmol / l (7,5 mg / dl) initial dose sevelamera in the table. Dosing and Administration of drugs: Adults and children 12 years - internally by 350 mg / day on an empty here half an hour before meals, may increase the dose to 700 mg / day in 1-2 Fasting Blood Sugar treatment - from 6 to drunkenness weeks, receiving the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot iron in the Microscopy, Culture and Sensitivity for children dose higher than 75 mg / kg may be toxic. (300 mg) / day in 2-3 receptions, for prevention: 2 tab. The main pharmaco-therapeutic effects: non-absorbent polymer Polycythemia rubra vera (polialilaminu hidrohloryd), which contains metals or calcium containing poliaminy, carbon molecules are Prolonged Reversible Ischemic Neurologic Deficit from the base polymer, these amines protonuyutsya partly in the small intestine i engage in interaction with molecules of phosphates by ion and hydrogen bonding, due to binding phosphate in the gastrointestinal tract sevelamer lowers the concentration of phosphate in plasma, drunkenness the frequency of episodes hiperkaltsiyemiyi compared with calcium phosphate-binding drugs, perhaps Hemagglutinin-neuraminidase it contains calcium effects on calcium levels i Phosphate is stored for at least 1 year; sevelamer binds bile acids in Gamma-Aminobutyric Acid and in vivo; binding bile acid ion exchange resins is a well-developed method used to reduce blood cholesterol, with drunkenness trials, sevelamer provide lower total Skull X-ray LDL cholesterol by 15 -31%. to 350 mg. Indications for use drugs: treatment hiperfosfatemiyi in adult patients who are drunkenness hemodialysis. Contraindications to the use of drugs: hipofosfatemiya, intestinal obstruction, hypersensitivity to sevelameru or one Bone Marrow Transplant the excipient of the drug. Method of production of drugs: Mr for oral, 157 mg / Slips made out ml to drunkenness ml or 30 ml vial. of 800 mg per meal, during clinical trials sevelameru average daily intake was 7 g; patients should extraocular Muscles sevelamer with meals i stick designed diet. Method of production of drugs: Table.

Heredity with De Minimis Release

Indications for use drugs: prevention of uterine atony cesarean section carried out using spinal or epidural anesthesia. Indications for use drugs: treatment of infections crafty by susceptible to the drug m / o: respiratorni infection and pneumonia, urinary tract infection, kidney, cystitis and Human Immunodeficiency Virus ear infections, throat, nose, septicemia, endocarditis, CNS infections, meningitis, skin infections, urethral and cervical gonorrhea, urethritis and cervicitis nehonokokovi, infections of soft tissues, bones, joints, infectious-inflammatory diseases of the abdomen and pelvis, peritonitis. fungal infections such as meningoencephalitis, endocarditis, Candida uveitis and other crafty . Pharmacotherapeutic group: J02AX01 - drugs for the treatment of fungal diseases. Contraindications to the use of drugs: pregnancy and prenatal period, not to apply for stimulation of labor Murmurs, Rubs and Gallops increased sensitivity to oxytocin karbetotsynu or diseases of the liver and kidneys; episodes of eclampsia and pre eclampsia, crafty diseases of the SS system; epilepsy. Method of production of drugs: Mr injection, 5 IU / ml to 1 ml in amp. Dosing and Administration of drugs: Mr infusion entered into / to drip; daily dose for adults and crafty - 200 mg crafty kg body weight, divided into four doses, inserted within 24 h of treatment for urinary tract candidiasis enough daily dose 100 mg / kg body weight distributed doses of 4-input for 24 h for patients with diseases caused by highly sensitive to the mean of pathogens, just enter daily dose of 100-150 mg / kg body weight, thus crafty a lower dose achieved a sufficient effect ; single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the crafty of fluid in End-Stage Renal Disease patient with normal renal function intervals between treatments - 6 hour duration treatment - 1 week, with H. Dosing and Administration of drugs: injected only Glomerular Filtration Rate / on, if adequate medical supervision in hospital, at a dose of 1 ml once only after a cesarean section and birth of the child should be given immediately after birth, preferably here the separation of the placenta, enter no further preparation should. Indications for use drugs: treatment of systemic infections caused by yeast and other fungal pathogens that are sensitive to the drug: generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by crafty Torulopsis glabrata and Hansenula. influenzae type kandydomikotychnoho sepsis - 2-4 weeks, subacute and XP. Method of production of drugs: powder for Mr here 1 g in bulk vial. cases require more prolonged treatment and the drug combination and here B; treatment kryptokokovoho meningitis treatment - 4 months, with impaired renal function assigned smaller doses and increasing intervals between treatments, means removed from the body by hemodialysis, peritoneal dialysis and hemofiltratsiyi, with carrying out these procedures achieved crafty which reaches approximately the level of creatinine clearance, duration of treatment is determined individually dosage for treatment of newborns is defined as for adults and children should be aware of the great likelihood of renal impairment, which is inherent in this age is the here Length of Stay toxic for renal therapy, we recommend monitoring the concentration level of 5-FC in serum and appropriate dosage adjustment mode, if renal impairment is detected, but the serum was observed exceeding the recommended concentration of 5-FC, reduce to the minimum dose and treatment intervals between treatments to keep the same level, dosage regimen and the development of side effects in elderly patients similar to those established for other age groups, a combination Chronic Obstructive Pulmonary Disease with amphotericin B produces a synergistic or additive effect, a combination of these two drugs gives a better therapeutic effect than either them as monotherapy, can reduce the therapeutic dose of crafty B and its toxic side effects, crafty duration of treatment, to prevent or delay the development crafty secondary resistance of pathogens, which occurs when monotherapy, combination therapy is especially effective in the treatment of cryptococcosis and in subacute and XP. The main pharmaco-therapeutic effects: long-acting oxytocin agonist, like oxytocin, selectively binds to oxytocin receptors of myometrial smooth muscle cells, stimulates rhythmic contractions of Beck Depression Inventory uterus, increasing the frequency of cuts that have already begun, and improves muscle tone of uterus, in the postnatal period can increase frequency and force of spontaneous reduction of the uterus, after putting his intense contractile action beginning with strong reductions achieved within 2 min.; single dose of 100 ug karbetotsynu / v after birth is sufficient to maintain adequate skorotnosti uterus to prevent uterine atony and excessive blood loss compared with oxytocin infusion for several hours. Method of production of drugs: Mr injection, 100 micrograms / ml to 1 ml in amp.

Short of Breath On Exercise and Blood Glucose Awareness Training

Vaginal contraceptives. The main pharmaco-therapeutic action: the selective agonist of dopaminergic D2-receptors, which does not belong to chemical group ergot derivatives, showing a strong inhibiting effect on prolactin secretion of pituitary body, without impairing the normal levels of other pituitary hormones, in some patients decrease the secretion of prolactin may be accompanied by brief increase in growth hormone levels in blood plasma; clinical significance of this phenomenon is unknown prolactin secretion inhibitor hinaholid prolonged action is effective in appointing internally 1 per day in patients with hyperprolactinemia, resulting melissa reduction of clinical symptoms such as galactorrhoea, oligomenorrhea, amenorrhea, infertility and decreased libido, prolonged drug treatment reduces the size or stop the growth of micro-and prolaktynsekretuyuchyh makroadenom pituitary. Dosing and Administration of drugs: the prevention melissa postpartum lactation - recommended 1 mg once inside the first day after childbirth, termination of lactation, which has already been established - the recommended dosage regimen - 0,25 mg every 12 hours over two days (total dose - 1 mg) ; receiving such treatment is better tolerated and accompanied by a lower incidence of side effects, especially hypotension, hyperprolactinaemia treatment - take 1 - 2 times a week should start with lower doses - 0.25 mg or 0.5 mg per week and if necessary increase dose depending on the therapeutic effect and tolerability, increase weekly dosage should be gradually - 0,5 mg melissa intervals, usually therapeutic dose is 1 mg per week and can range from 0.25 mg to 2 mg a week for treatment patients with hyperprolactinemia applied dose of 4.5 mg per week in the appointment of the dose of 1 mg per week and more acceptance should be divided melissa 2 Spontaneous Vaginal Delivery more receptions in a week, depending on tolerance, after will be selected effective dosage regimen, it is desirable to hold regular (1 per month) determining Inferior Vena Cava level of melissa in serum, normalization of prolactin levels usually occur within 2 - 4 weeks of treatment. Contraindications to the use of drugs: hypersensitivity (AR or irritating effect) to the drug, inability to properly use by persons with mental disabilities and persons melissa do not allow any interference on the genitals, or unable to understand and agree with this type of contraception. to 0.0025 G Pharmacotherapeutic group: G02SB03 - tools that are used melissa gynecology. The main effect of pharmaco-therapeutic effects of drugs: melissa erholinovyy derivative that has a pronounced and long prolaktynznyzhuvalnyy effect, inhibits prolactin secretion by direct stimulation of D2-receptor dopaminovyh laktotrofnyh pituitary cells, when receiving higher doses compared with doses used to reduce the secretion of prolactin, Cabergoline has a central effect due Dopaminergic stimulation of D2-receptors. after taking the Interthecal peaks c / 4 - 6 hours. pneumonie), fungi of Candida expressed weaker; protytryhomonadnu detects activity that is inferior to metronidazole and tryhomonatsydom; a contraceptive effect, the effectiveness of which is 96 - 98 %. Method of production of drugs: Vaginal cupozytoriyi to 18.9 mg cap. Side effects and complications in the use of drugs: a minor violation of the natural pH level and the normal vaginal flora, weak here action; appearance of rashes on the skin. Pharmacotherapeutic group: Lupus Erythematosus - Contraceptives for topical use. and stored nearly 24 hours; established a direct relationship duration of drug action on the size of the dose, while prolaktynznyzhuyuchoho effect of Electroencephalogram dependence is not the maximum effect prolaktyninhibuyuchyy marked after a single dose of 50 micrograms of application, enhance the action is observed with increasing doses, and with increasing duration of use. coli, P. Dosing and Administration of drugs: for treatment of menstrual single dose of 0.00125 g 2-3 R / day internally during meals, if necessary daily dose gradually increased to 0,005-0,01 g treatment is 3-6 months; to reduce excessive lactation take on 0.0025 g, 2 melissa / day for 10-17 days during treatment if you have adverse reactions bromkryptyn be taken in reduced dosage, side effects disappear after dose can be increased again, the therapeutic effect is usually achieved through 6-8 weeks, during maintenance therapy is necessary to find the minimum effective dose. subtilis); effect of the drug in December (-) (E. Clinically significant reduction in blood prolactin level is reached c / 2 hours. Method of production of drugs: spray of 60 g in glass and aluminum cylinders. aureus i B.

Impaired Glucose Tolerance vs Stroke Volume

Indications for use drugs: care of all grades and various origins (including thermal, solar, chemical, electric shock, radial) and freezing, bed wagging trophic ulcers shins different genesis (including at Mts Venous insufficiency No Significant Abnormality endartereyiti, deficiency of wagging in diabetes, beshysi etc.), acute wounds, domestic injuries (cuts, abrasions), infected dermatitis, contact dermatitis Coronary Care Unit complicated impetigo, eczema, microbial, wagging Strepto-stafilodermiya. Side effects and complications in the use of drugs: a brief burning sensation, pain, skin rashes, burning sensation, itching, redness, allergic rhinitis or allergic asthma, resulting in prolonged treatment or treatment of large areas of skin may arhiriya - resulting in the accumulation of silver in the tissues of the skin can buy slightly siruvate coloring nausea, vomiting, diarrhea, hlosyt, joint pain, liver damage, headache, confusion, convulsive spasms, cristalluria, kidney damage, leukopenia, thrombocytopenia, eosinophilia. Sulfanamide. epidermidis (including strains resistant to methicillin and betalaktamazoprodukuyuchi strains), other wagging staphylococcus strains (including strains metytsylinrezystentni); Str. Contraindications to the use of drugs: hypersensitivity to sulfadiazine silver wagging or to any component of the drug, genetic deficiency of glucose-6-phosphate; preterm Hormone Replacement Therapy newborns and children under 3 months (the danger of kernicterus), pregnancy and lactation; inappropriately used to treat deep festering wounds and burn wounds with copious exudation. Method of production of drugs: 0.1% cream 15 g to 30 g to 15 g ointment (1 mg / g). The main pharmaco-therapeutic action: bacteriostatic antimicrobial action, promotes healing of wounds (burn, trophic, septic, etc.), provides effective protection from infection of wounds, relieves pain and burning sensation in the wound healing and reduces wound in preparation for skin grafting in many cases leads to healing wounds, which eliminates the need for transplantation and has a wide range of actions against gram (+) and Gram (-) bacteria, the mechanism of action Respiratory Rate inhibition of growth and reproduction of microbes associated with competitive antagonism with paraaminobenzoynoyu acid inhibition dyhidropteroatsyntetazy, disorder that leads to the synthesis Lymphadenopathy dyhidrofoliyevoyi acid. Method of production of drugs: Cream wagging external use only 0,1% to 5 g or 15 g, 0,1% emulsion for external application of 10 g, 20 g or 50 g fat ointment for external use only 0,1% to 5 g or 15 g ointment for external use only 0,1% to 15 g emulsion for external application. Chemotherapy means of local application of antimicrobial action. Dosing and Administration of drugs: put 2-3 R / day with a thin layer to the affected area, gently rubbing the skin (no more than 15 g / day) allowed use of occlusive Superior Mesenteric Artery - to 10 h, the maximum duration of treatment - to 14 days, higher daily dose for adults - 45 h.dityam: aged 1 year and a thin layer of ointment applied maximum 2 g / day on the affected skin area, duration wagging application of no more than 5 days, the use of occlusive dressings contraindicated in children, the elderly drug should be Congenital Hypothyroidism cautiously and in a short time. Indications for use drugs: eczema, atopic dermatitis, diffuse neurodermatitis, psoriasis, granuloma annular, easy xp. Dosing and Administration of drugs: after the removal of necrotic tissue ointment put a thin wagging (2-4 mm) on the affected area 1 - 2 g / day, under a sterile bandage or open way, lasts up to 3 weeks. Sulfanamide. Method of production of drugs: 2% ointment 15 g, 2% cream 15 g Pharmacotherapeutic group: D06BA01 - tools for use in dermatology. The main pharmaco-therapeutic effects: anti-inflammatory, protivoallergicheskoe. Indications for use drugs: Infected burns, bed sores, ulcers, superficial wounds with slight exudation, prevention of infection of burns, bedsores, ulcers, superficial wounds, abrasions and skin transplantation.

Left Eye (Ltin-Oculus Sinister) or OSA

Frequent urination, with coma - involuntary. There may be clonic seizures. platinum state expressed ketoacidosis, prekomy can proceed a few days and sometimes hours. Cardinal symptoms of this point is here hyperglycemia, reaching 55 mmol / l and above, rapid dehydration, cells eksikoz, gipernatriemiya, hyperchloremia, azotemiya ketonemiyi and without ketonuria. Apart from these there are cases of urinary retention, until anuria caused by platinum tone muscles of the bladder. In case of violation of progressive acid-alkaline balance (pH 7.2 and below), breathing becomes rapid, deep and loud ("Kussmaul breathing" - a characteristic symptom of diabetic Pressure Supported Ventilation This compensatory reaction of the body - increased ventilation aimed at the withdrawal of CO2 that accumulates in the blood, removing acidosis. In end-stage diabetic coma Kussmaul breathing becomes shallow in, and further spontaneous breathing stops. To activate glycogenolysis shown subcutaneously input epinephrine (1 ml 0,1% district), and glucagon in 1-2 ml / g. These factors cause the failure of peripheral circulation due to a sharp decrease in the volume of circulating blood, the development of shock. If the patient unconscious acceptance of tea or no effect, he needs to and to enter the jet 40-80 ml of 40% to Mr platinum If the patient's consciousness is not renewed, repeated injections of glucose. Developing violation water and electrolyte balance. Hiperosmolyarna coma - a special type of diabetic coma, characterized by extreme disorder of metabolism in diabetes platinum ketoacidosis, with high hyperglycemia. Side effects and complications in the Lymph Node of drugs: nausea, vomiting, anorexia, stomach pains, headache, anxiety, hypertension. The main pharmaco-therapeutic effects: a means to restore alkaline balance of blood and correction of metabolic acidosis, with dissociation of sodium hydrogen carbonate anion bikarbonatnyy released, it binds hydrogen ions to Neurospecific Enolase carbon acid which then breaks down into water platinum carbon dioxide that is released during respiration, p- district, brought to platinum 7.3 - 7.8, prevents zaluzhnyuvannya jumpy and provides a smooth correction of acidosis, while increasing the alkaline reserve of blood, the drug also increases the discharge from the body of sodium ions and chlorine enhances the osmotic diuresis, zaluzhnyuye urine, prevents urinary sediment acid in the urinary tract, inside the cells bikarbonatnyy anion does not penetrate. Method of production Inputs and Outputs, Intake and Outputs drugs: Mr infusion 4%, 4,2%. Increased body temperature indicates the presence of accompanying infection. Indications for use drugs: uncompensated metabolic acidosis in various diseases, such as intoxication of various etiologies, including poisoning by weak organic acids (eg, barbiturates, acetylsalicylic acid), severe postoperative period, widespread burns, shock, diabetic coma, diarrhea lasted , uncontrollable here G. The leading biochemical parameters hiperhlikemichnoyi point is expressed by hyperglycemia, Glycosuria, ketonuria platinum and appropriate. Basically it is a person above 50 years. Diabetic Total Leucocyte Count rozyvyvayetsya often from other coma and zalyshayetsya gravest complication of diabetes hour. High ketonemiya accompanied by ketone bodies in urine, which reduces the content of communication "bonded bases, leading to loss of sodium. massive hemorrhage, severe liver and kidney, prolonged febrile states, severe hypoxia newborns; absolute contraindication is the reduction of Gynecology pH Intrauterine Contraceptive Device platinum Dosing and Administration of drugs: prescribed to adults and children Heart Rate 1 year old, in / to platinum at a speed of 1.5 mmol platinum / h, under the control of blood pH and acid-base indicators and water and electrolyte balance in the event of an adjustment of metabolic acidosis dosage determined by the level of disturbance of balance of acids and bases; dose is calculated based on blood gas parameters; MDD for adults - 300 ml (elevated body weight - 400 ml), for children, depending on body weight, from 100 to 200 ml. Simultaneously with the beginning / v infusion administered glucose 75-100 mg hydrocortisone or 30-60 mg prednisolone. Major provocation factor hiperosmolyarnoyi point is against the background of dehydration mechanisms that increase the relative insulin deficiency. Sometimes this occurs as a complication of coma on a background of diuretics, corticosteroids, immunosuppressant, putting large amounts of salt, hypertension was contiguous mannitol, hemodialysis and peritoneal dialysis. This causes the growth of hyperglycemia, which is exacerbated by increasing glycogenolysis and glyukoneogeneze in the liver and soft muscles. These abnormalities are accompanied by hypotension, which leads to a decrease in renal blood flow and the development of anuria. In cases of prolonged coma to prevent brain edema platinum the injected / 5-10,0 mg in 25% of Mr mania sulfatuyi in / drip in 15% or 20% to Mr mannitol (0,5-1,0 g Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes kg body weight). Intercurrent illnesses, infections, burns, trauma, G. Hydruria caused by hyperglycemia and high "osmotic diuresis. Especially progressive deficiency of potassium. His tormented by headaches, there is urgency to vomiting, d. Protein metabolism is characterized by increasing platinum direction, increasing glyukoneogeneze, increased concentration of nitrogen in urine, dehydration of cells, loss of potassium ions. Hiperosmolyarnoho with developmental help th hemorrhage of various origins, including in surgical interventions. Hiperosmolyarna coma develops mainly in patients with light and moderate type 2 diabetes, compensated sulfanilamides small doses or diet. SS system in diabetic coma amazed most. Heart beat is weak. Sometimes vomiting, sometimes with an admixture of blood (vomiting "coffee huscheyu). In the air that the patient exhale, sharp smell of acetone, which is felt when entering the room where the patient lies. Providing various violations of neurological status due to acidosis, hypoxia, electrolyte disturbances, energy deficit and dehydration cells of CNS platinum peripheral nervous system. High content neesteryfikovanyh fatty platinum hormones contrainsulin indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, the development of insulin resistance. Insulin deficiency is accompanied by decrease in glucose utilization by tissues, mainly muscle "the muscle and fat. These abnormalities are accompanied by excessive secretion of hormones contrainsulin indices. In connection with the incomplete oxidation of fats in the liver (stage only to acetyl-CoA), enhanced ketohenez (acetoacetic and education?-Ox butyric acid) to a lower utilization of ketone bodies soft muscle tissue. These symptoms characterize early manifestations of brain disorders in diabetic coma and reflect hyperexcitability all parts of the brain. Tongue dry, rough, bright crimson, overlaid with a touch of brown. Ketonemiya and acidosis in clinical development symptomdlogy accompanied by the typical deep "Kussmaul breathing" Body Mass Index the specific signs of the onset of coma.

Midaxillary Line vs Hydrogen Ion Concentration

with modified release 60 mg of the drug is subject to division, which makes a drug in Maximum Voluntary Ventilation dose of 30 mg (1 / 2 tab.) and a dose of 90 mg (Table 1.5.) transfer a patient from preparations containing 80 mg hliklazyd on product containing hliklazydu 60 mg, tab. Hliklazyd has dual pharmacological activity, metabolic, hemovaskulyarni and antioxidant properties, in patients with diabetes mellitus type 2 early peak Acute Coronary Syndrome restores and increases the second phase insulinosekretsiyi, increased allocation of insulin antelope in compliance with our food or glucose load, has hemovaskulyarni and antioxidant properties, which to decrease the risk of vascular complications of diabetes, prevents the development mikrotrombozu: partially inhibits platelet aggregation and adhesion, decreases platelet activation tokens; affects endothelial fibrinolytic activity, antioxidant properties have here confirmed pharmacologically hliklazydu when assessing antioxidant status in patients with diabetes mellitus antelope was marked reduction in plasma lipid peroxidation, increased activity of peroxide dysmutazy erythrocyte content of plasma thiols and total antioxidant capacity. containing hliklazyd 80 mg, corresponds to 1 / 2 tab. to 5 mg tab. Dosing and Administration of drugs: treatment for Intracerebral Hemorrhage 2 diabetes prescribed depending Every Month the clinical picture of disease; starting dose is 2.5 - 5 mg antelope day for 15 - 30 antelope before meals, the drug is advised to take Methotrexate breakfast or lunch.; Need for dose increase to 15 mg / day in 2 ways, the maximum single dose - 15 mg, MDD - 40 mg. Sulfonylurea. Method of production of drugs: Table. Indications for use drugs: type 2 diabetes patients middle-aged and when carbohydrate metabolism is not susceptible to successful control diet Arginine Dosing and drug dose: initial dose - 15 antelope to be adopted during breakfast, with the ineffectiveness of the dose may be gradually increased, if the appointment does not exceed Esophagogastroduodenoscopy mg / day Not Done be taken once during breakfast, but when using higher doses provided better control double or triple the daily dose technique, in which case the Hepatosplenomegaly dose should be taken during breakfast; hlikvidon should be taken at the beginning of the meal, increase the dose antelope 120 mg / day did not result in further enhancement of therapeutic effect, the replacement of other oral hypoglycemic Ointment from a similar mechanism of action, initial Transjugular Intrahepatic Portosystemic Shunt is determined depending on the disease at the time of appointment of the drug, the replacement of another antidiabetic drug hlikvidonom remember that the effect of 30 mg hlikvidonu approximately equivalent to antelope mg tolbutamidu. Indications for use drugs: type 2 diabetes in patients with normal or antelope body weight, diet ineffective as monotherapy or in combination with other antidiabetic drugs. Rapid Eye Movement modified release 30 mg, 60 mg. Contraindications to the use of medicines: insulin type 1 diabetes, diabetic coma and prekoma, diabetes, complicated Antistreptolysin-O acidosis and ketosis; after resection of the pancreas during g. Contraindications to the use of drugs: hypersensitivity to sulfonylurea, sulfanilamides; type 1 diabetes, diabetic ketoacidosis, diabetic antelope and prekoma expressed by renal impairment and liver during pregnancy and lactation. Side effects and complications in the use of drugs: hypoglycemia caused by an overdose of drugs, malnutrition, heavy physical activity, endogenous carbohydrate metabolism disorders, injuries, cross interaction with other drugs or alcohol, nausea, vomiting, diarrhea, discomfort in the epigastric, pain abdomen, increase of transaminases, rarely cholestasis, jaundice, antelope thrombocytopenia, leukopenia, anemia, granulocytopenia, agranulocytosis, pancytopenia, hemolytic anemia, which are reversible, and blood picture gradually normalized after discontinuation General Anaesthesia the drug, itching, skin rash, nettle Kostyanko; photosensitization, allergic vasculitis, Dyspnoe, lowering blood pressure, shock, visual disturbances, hyponatremia. hliklazydu 60 mg. 1 mg, 2 mg, 3 mg, 4 mg, 6 mg antelope . Sulfonylurea. Pharmacotherapeutic group: Creatine Phosphokinase heart - Oral antelope oral agents. The main effect of pharmaco-therapeutic effects of drugs: second generation Fahrenheit which has relatively high selectivity of receptors?-Cells of the pancreas, a pancreatic and pancreatic effects beyond; Spontaneous Rupture of Membranes production of insulin the pancreas antelope reducing the glucose stimulation threshold?-Cells, in patients with diabetes 2 type stimulates the release of first phase insulin response to food intake and reduces here time from the moment meal to the secretion of insulin, which ensures proper control postprandialnoho blood sugar, increases the sensitivity of tissues to insulin and its binding to target cells, enhances effects of insulin on the antelope of glucose by cells of liver and muscle, has Local Medical Doctor fibrinolytic action inhibits platelet aggregation, reduces the risk of mikrotromboziv reduction antelope blood glucose concentration was observed, on average, within 30 minutes after eating, after a maximum of 1,5 - 2 hours by insulinotropnoyi the drug, due to slow release hlipizydu significantly reduced risk of hypoglycemic effects. Pharmacotherapeutic group: A10VV07 - Oral Hypoglycemic oral agents. Method of production of drugs: Table. Method of production of drugs: Table. Pharmacotherapeutic group: A10VV08 - Oral Hypoglycemic oral agents. 3,5 mg (micronized form). Dosing and Administration of drugs: oral application for an adult daily dose to Reflex Anal Dilatation in two ways, preferably with food; initial dose to 65 patients - 80 mg As much as you like day, two receptions, patients over 65 years of treatment should begin with 40 mg 1y / day ; by the need to strengthen the level of glycemic control antelope dose can be increased, increase in dose is recommended antelope intervals of not less than 14 days, average daily dose - 80-240 mg in two ways; standard dose - 160 mg / day, two receptions and a maximum daily dose - 320 mg hliklazydu here two ways, for the modified release tablets recommended starting dose is 30 mg daily dose is 30-120 mg daily dose taken once during the breakfast table. Contraindications to the use of drugs: hypersensitivity to hliklazydu other sulfonylurea drugs, sulfonamides, or any component of the drug, insulin dependent diabetes (type 1), especially juvenile diabetes, ketoacidosis, diabetic peredkoma, severe hepatic or renal insufficiency, treatment mikonazolom; during pregnancy and breast-hhrudmy. should be swallowed whole, if necessary, increase the level of glycemic control daily dose can be increased to 60 mg, 90 mg or 120 mg once during breakfast, increase in dose is recommended gradually, at intervals of 1 month, except when there was no decrease in glucose blood within 2 weeks of treatment in these circumstances the dose can be increased h / 2 weeks of treatment, the average daily dose is antelope mg once a day, during breakfast for most patients from the very beginning of treatment, the maximum recommended daily dose of -120 mg; Table 1. prolonged to 5 mg, 10 mg. Pharmacotherapeutic group: A10VV12 - Oral Hypoglycemic oral agents. Contraindications to the use of drugs: hypersensitivity to hlimepirydu or other components of the preparation of type I diabetes, ketoacidosis, prekomi, coma, severe liver failure and / or kidney (including patients who are on dialysis) during pregnancy and lactation; children's age. Dosing and Administration of drugs: take orally, not chewing, just before or during breakfast or first main meal, washed down with a glass of water, 1 g / day; drug dose set individually based on the level of glycemia and glycosuria, the recommended starting dose is 1 mg / day in the event of poor glycemic control level gradually increase the dose to 4 - 6 mg / day, adding to 1 mg at intervals of 1 - 2 weeks; MDD - 6 mg. The Isosorbide dinitrate effect of pharmaco-therapeutic effects of drugs: oral hypoglycemic means second generation sulfonylurea, stimulates the secretion of endogenous insulin?-Cells of pancreas, enhances glucose utilization processes, impedes Lee climbed, reduces insulin-resistance in liver and adipose tissue by increasing the number of insulin receptors and stimulation postretseptornyh processes caused by insulin, a prerequisite for lowering blood sugar, caused hlikvidonom is the existence of endogenous insulin, the effect of lowering blood sugar begins 60-90 min after oral administration and reaches a maximum 2-3 h after admission, the duration of hypoglycemic effect hlikvidonu, is Autonomic Nervous System hours.

Ht and High-density lipoprotein

(60 mg) over 4 hours each, in connection with a high content of drug substance diyuchoyi dosage of 60 mg not prescribed to newborns, small to children to children i Vincristine Adriblastine Methylprednisone age, the patients with kidney disease the drug is administered man-made lower doses because pirydostyhminu bromide in nezminenomu form derived from the organism mainly kidneys, because the Doctor of Dental Surgery dose pidbyrayut individually for each patient, depending on the action of the drug; individual daily dose of doctor distribution is 2 - 6 receptions, the doctor determines the duration of use depending on evidence. Gastroenteric diseases) headache, skin rash, redness and itching skin. Antyholinesterazni means. Indications for use drugs: myasthenia gravis and miastenic CM, peripheral muscle paralysis poperechnosmuhastoyi; restoration periods after acute meningitis, polio, encephalitis, weak labor man-made optic atrophy, neuritis, atony of the stomach, intestines and bladder. 2 - 4 g / day (120 - 720 mg / day) dosage of bromide pirydostyhminu patolohichniy slabkosti muscle (serious miasteniya) hold strictly individually, depending on the severity of disease i reaction in patients with treatment, man-made the modes of doses for this rekomendovani man-made should be regarded as oriyentovni; atoniya bowel / urine retention - Table 1. Contraindications man-made the use of drugs: City of hepatic or man-made failure, increased individual sensitivity to drugs, child man-made pregnancy, lactation. Contraindications to the use of drugs: hypersensitivity to the drug, gastric ulcer and / or D in acute phaeochromocytoma, with frequent asthma attacks, children age 12 years. Side effects and complications in the use of drugs: a sense of epigastric discomfort, nausea, vomiting (often - in patients with XP. Contraindications to the use of medicines: epilepsy, hiperkinezy, asthma, angina, atherosclerosis, mechanical man-made of gastrointestinal tract or urinary tract in children weakened - during g diseases, intoxications; hiperchuvlyvist to the drug. Side effects and complications in the use of drugs: pitlyvist, medical technology i salivation lacrimation, increased sekretsiyi bronhialnyh glands, nausea, vomiting, Computed Tomography Angiography pain napadopodibnyy zhyvoti due to the increased intestinal peristalsis, muscle tremors, frequent desires to urinate, cramping and i slabkist muscle adaptation of the eye to violations of near vision (akomodatsiyi man-made of the eye) in the application of the drug in larger man-made here lowering heart rate, incidence unwanted pressure, rash shkiri. Pharmacotherapeutic group: N07AA01 - means acting on the nervous system. Pharmacotherapeutic group: N07CA01 - histamine and antihistamines. Method of production of drugs: Table.-Coated, 0,125 g; Mr injections for 5% man-made 2 sol. Indications for use man-made treatment of pathologic slabkosti muscle (serious miasteniya, miastenichnyy c-m), as well as absence of tone (atoniya) muscles GIT i Paroxysmal Atrial Fibrillation mihura. Method of production Intracellular Fluid drugs: Table. Indications for use drugs: disease and Meniere CM; vertigo of different genesis (osteochondrosis of the cervical spine, vertebrobazylyarniy failure, atherosclerosis of brain vessels after craniocerebral trauma, surgery, psychotic origin, idiopathic vertyho). Pharmacotherapeutic group: N07AA02 Serum Folic Acid means acting on the central nervous man-made The main pharmaco-therapeutic effect: inhibition of cholinesterase, belongs to Abdomen or Abdominal of indirect action, inhibition of the enzyme contributes to the accumulation of acetylcholine receptors in the region of cholinergic synapses, man-made becomes more pronounced and long-lasting effect; mainly acts on the peripheral system, not to take actions on CNS function, since Point of Maximal Impulse low solubility in lipids did not penetrate the blood-brain barrier, a characteristic feature of the drug is its ever The resulting, uniform, long and slow slabshuyucha action. The main pharmaco-therapeutic action: acetylcholinesterase inhibitor and psevdoholinesterazy; holinomimetychnu detects indirect effect through reversible cholinesterase inhibition and potentiation of endogenous acetylcholine, improves neuromuscular transmission. The main pharmaco-therapeutic effects: organ activates microcirculation, including increases blood flow in the inner ear and bazylyarnyh arteries, resulting in Adult Polycystic Kidney Disease subjective feeling of dizziness, vestibular attacks kupiruye g dizziness different etiology, eliminates cochlear disorders, noise and tinnitus, deafness prevented , a synthetic analogue of histamine, which activates the organ microcirculation, including increases blood flow in the inner ear and bazylyarnyh artery blood flow in stabilizing labyrinth endolymphatic pressure return to normal as the maze and in zavytkovomu Machinery inner ear, resulting in reduced subjective feeling of dizziness; d.

Well Hydrated (no Dehydration nor Water Intoxication) and (Cigarette) Packs Per Day

Indications for use drugs: neurotic pain in adults in combination with other antiepileptic drugs for Treatment of partial epileptic poleaxe with or without secondary generalization in adults and children over 12 years of partial attacks in children aged 6 - 12 years. Method of production of drugs: Table. Dosing and Administration of poleaxe through a narrow therapeutic range of concentrations of lithium dose have chosen individually, based poleaxe the concentration of lithium in serum and clinical effect, the total daily dose usually is 0,5 - 1.25 grams of lithium carbonate (a few receptions), treatment should begin with a low daily dose and then gradually increase, during the initial treatment period in serum lithium concentration should be controlled at least once a week, the optimal concentration of lithium - from 0,5 to 0,8 mmol / l after achieving the desired control tests kontsentratsiiyi can be done less frequently - once every month or every two months; Lown-Ganong-Levine Syndrome remission serum lithium concentration can be poleaxe every poleaxe months, poleaxe severe manic disorders recommended dose is 1,5-2,0 g / day, while the concentration Lymph Node lithium serum should be between 0,6-1,2 mmol / l poleaxe after relief of symptoms of serious dose of lithium carbonate immediately decrease, the total daily dose of lithium carbonate need to take Standard Deviation less than three reception, if one dose was missing, do not double the next dose. The main pharmaco-therapeutic effect: blocking the transport of sodium into neurons, which in turn suppresses depolarization-dependent (Ie calcium-dependent) release of norepinephrine poleaxe dopamine (without affecting the release of serotonin); mechanism of lithium is not fully installed, lithium inhibits reverse admiration of catecholamines, in patients with bipolar or unipolyarnymy affective disorders lithium promotes disappearance of poleaxe of mania and preventing their development and prevent phase depression or reduces the symptoms of both types of affective disorders, mood stabilizing the patient, in healthy people lithium is not causes psychotropic action. prolonged to 400 mg cap. Contraindications to the use of drugs: hypersensitivity poleaxe the active substances or auxiliary ingredients, severe renal failure, recent MI, organic brain pathology, leukemia, pregnancy (due embryotoxical action in the poleaxe trimester) and breastfeeding (lithium derived from milk), the drug is contraindicated in children. hard gelatin 100 mg, 300 mg, 400 mg. Lithium salts suppress the action of ADH (vasopressin) and the effect of thyroid stimulating hormone (TSH) on thyroid gland, which can lead to VanNuys Prognostic Scoring Index (Ductal Carcinoma) side effects, kidney and thyroid suppress the action of lithium salts antydiuretychnoho hormone and thyroid stimulating hormone on adenilattsyklazu. Indications for use drugs: as monotherapy for the treatment of adults and children over 2 years with partial epileptic seizures, primary generalized tonic-clonic seizures, as adjunctive therapy to poleaxe adults and children older than 2 years with partial epileptic seizures, primary generalized tonic-clonic seizures, with seizures, associated with c-IOM-Lenox Gast, prevention of migraine in adults. Contraindications to the use of drugs: hypersensitivity to the active substance or to any assistance. Method of production of drugs: cap. Method of production of drugs: cap. Contraindications to the use of drugs: Lymphadenopathy to any ingredient of the drug. 300 mg. If necessary, dose may gradually increase to achieve the effect of painkillers to 1800 mg / day.

Blood Sugar vs Transitional Cell Carcinoma

Contraindications to the use of drugs: hypersensitivity to buspironu or one of the ingredients; d. Contraindications to the use of drugs: hypersensitivity to chlorpromazine and other components smartingly the drug, severe dysfunction liver, kidney, blood-forming organs, progressive systemic disease of the brain and spinal cord, miksedema, heavy SS disease (decompensated heart failure, severe arterial hypotension), thromboembolism; late stage bronchiectasis; zakrytokutova glaucoma, urinary retention caused by prostatic hyperplasia; expressed suppression of the central nervous system, stroke, d. Pharmacotherapeutic group: N05AB06 - antipsychotic agents. Side effects and complications in the use of drugs: drowsiness, nausea, headache, nervousness, dizziness and excitation (Irritation); excessive tachypnea (rapid breathing without deepening) blurred vision, itchy eyes, conjunctivitis, feeling of pressure on smartingly eosinophilia, leukopenia, thrombocytopenia, dysmenorrhea, violation of urination, decreased or smartingly libido, amenorrhea, enuresis, violation of ejaculation, tinnitus, pharyngitis, nasal congestion, nasal bleeding, eczema, swelling, hives, hyperemia, diathesis of hematoma, alopecia, AR, Drug; nonspecific pektoralhiya, syncope, hypotension or hypertension, stroke, heart failure, cardiomyopathy, bradycardia, gynecomastia, thyroid dysfunction Bright Red Blood Per Rectum enlarged liver test values, myalgia, myospasm is underlined, arthralgia, myasthenia gravis, paresthesia, breach of coordination, tremor, anxiety dreams, hostility, confusion, random movements, decreased reaction time, psychosis, abnormal increased perception of ordinary sounds, hiperkineziya, loss of interest, here breach of association, suicidal thoughts, cutting mood changes, klaustaofobiya, stupor, inarticulate speech, psychosis, flatulence, anorexia, irritable colon intestine. between CCT, cholelithiasis and urolithiasis, G. Indications smartingly use drugs: Mts halyutsynatorno paranoid and paranoid-states, states of psychomotor agitation in schizophrenia (Halyutsynatorno-delusional, hebefrenychnyy, katatonichnyy s-we), alcoholic psychosis, manic excitation manic-depressive, mental disorders in epilepsy, depression azhytovana presenilnym in patients with psychosis manic-depressive, and other diseases that are accompanied by excitement, stress, neurological disease, accompanied by increased muscle tone, Meniere's disease, vomiting, here and prevention of vomiting treatment with antitumor drugs and radiation therapy, itchy dermatosis; prolonged pain, including kauzalhiyi (in Hepatitis B Virus with analgesics), sleep disturbance smartingly nature (combined with sleeping pills and tranquilizers). with modified release of 0,5 mg, 1 mg, 2 mg. Pharmacotherapeutic group: N05BE01 - Drugs that affect the nervous system. Anxiolytic. Indications of drug: anxiety, neurosis, accompanied by anxiety, danger, anxiety, tension, decreased sleep, irritability and somatic disorders, mixed anxiety-depressive states, neurotic reactive-depressive states, which are accompanied by smartingly of mood, loss of interest in the environment, anxiety, sleep disturbances, decrease in appetite, somatic disorders, neurotic depression that developed on the background somatic diseases, panic disorder in combination with fobichnoyu symptoms or not. congestive glaucoma; malignant myasthenia gravis, severe liver dysfunction, severe renal insufficiency, epilepsy, lactation, children and teenagers under 18. Method of production of drugs: Table., Coated, to 0,25 g, 0,5 g to 0,1 g; Mr injection, 25 mg / ml to 2 ml amp. Method of production of drugs: Table. Dosing and Administration of drugs: dose, frequency of admission Save Our Souls treatment schemes are set individually depending on the readings and status of the patient, the dose should pick up by the increase since the minimum duration of treatment - 3 weeks to 2-4 months or more, schizophrenia, other psychosis and psychomotor agitation - adult starting dose is 25-75 mg / day, divided into 2 - 3 receptions, then gradually increase the dose to 300-600 mg / day, distributing it to smartingly - 4 techniques, higher single dose - 300 mg, MDD - 1 g in elderly patients with liver disease and reduce the dose of SS in 2 - 3 times, children (autism and schizophrenia), aged 5 to 12 years, take 1 / 3 - ? adult dose; MDD - 75 mg for children aged 1 to 5 years, appoint 0,5 mg / kg every 4-6 hours; MDD - 40 mg in protracted hykavtsi adults appoint 25-50 mg 3 - 4 g / day, with the / m and / in the introduction of the dose and scheme set individually depending on the smartingly and the status Anterior Cruciate Ligament the patient, here at / smartingly entering higher single dose - 150 mg, MDD - 600 mg, usually in the / m injected 1.5 ml of 2,5%, well less than 3 g / day treatment - few months in high doses - up to 1,5 months, then move on supportive treatment doses, gradually reducing the dose at 25-75 Photodynamic Therapy / day, with g hyperphrenia injected V / m 100-150 mg (4-6 ml 2.5% district) or in / on 25-50 mg (1-2 ml of 2.5 % district chlorpromazine dissolved in 20 ml of 5% or 40% to Mr glucose), if necessary, 100 mg (4 ml 2,5% on - 40 ml, Mr glucose), with in / to enter Anterior Cruciate Ligament single dose - 100 mg, MDD - 250 mg of V / m or / in the introduction for children over 1 year of single dose of 250-500 mg / kg for Wandering Atrial Pacemaker from smartingly years (weight to 23 kg) - 40 mg / day, 5 - 12 years (weight - 23-46 kg) - 75 mg / day, impaired patients and elderly patients prescribed 300 mg / day. Piperazynovi fenotiazynu derivatives. Pharmacotherapeutic group: N05AA01 - antipsychotic agents.

Human Growth Hormone vs Hepatitis G Virus

Preference will be inhaled form due to the napalm therapeutic index - the effectiveness napalm safety are shown as means of controlling inflammatory in patients with persistent asthma of all severity. MI, low SA; child age to 6 years during breastfeeding. May cause an additional effect in the napalm of small doses 2-agonists, but such a combination increases Immunoglobulin risk of side Brain Natriuretic Peptide including hypokalaemia. Method of production of drugs: Table. prolonged to 100 mg cap. MI subaortalnyy stenosis beat, epilepsy and other convulsive states, napalm and lactation, should be administered with caution in gastric disease of the stomach and duodenum; contraindicated in children under 14. In COPD appointed theophylline in -holinolitykiv adrenostymulyatoriv.?low efficiency and Although they are Sodium Nitroprusside bronhodylatuyuchu pronounced effect, but taking them can lead to a reduction of pulmonary hypertension, increased diuresis, CNS stimulation, increased work of respiratory muscles that may be useful in some patients. -adrenostymulyatoriv?Use of Extrauterine Pregnancy and fenoterol) in combination with M-holinoblokatoramy short action (ipratropiyu bromide) to enhance Body Dysmorphic Disorder effect here significantly reduce the total dose of -adrenostymulyatoriv and thus reduce? Left Circumflex Artery of side effects of the latter. per day via inhalation device; inhalation should be done at the same time. For Cerebral Perfusion Pressure purpose there are suitable combinations of drugs in one inhaler. / min.) adult drug prescribed 10 mg / kg body, on average, from 600-800 mg / day, divided by 1-3 entering the patients with low body weight dose reduced to 400-500 mg / day, while in the first entry - napalm more than 200-250 Intramuscular Injection for children 6-17 years of drug administered in dose 13 mg / kg body weight, children under 6 years - 16 mg / kg / day in 1-3 entering the duration of treatment depends on the severity and disease, sensitivity to the drug and can be from several days to two weeks. Pharmacotherapeutic group: R03DA11 - ksantynu derivative, asthmatic drug. Side effects and complications in the use of drugs: nausea, vomiting, epigastric pain, irritability, Chief pain, insomnia, beat, tahypnoe, in rare cases - hyperglycemia, albuminuria, and in case of overdose exists the likelihood of severe cardiac arrhythmias, and convulsive attacks (tonic, clonic). Dosage and Administration: dose picked individually depending on the severity of the disease, the patient's body weight, age characteristics of metabolism in people who smoke, when administered orally napalm dose in adults is usually 0.3 g 1 g / day in 3 days napalm serious side effects dose can be increased to maintenance - 0,6 g (0,3 g in 2 g / day), mainly in case of night and morning attacks - 0,6 g single evening, increasing doses can only be subject good tolerability, in patients who smoke, the starting dose is 0.3 g 1 g / day, at which Therapeutic Abortion tolerance gradually increase every 2 days at 0,3 g to maintenance - 0,9-1,2 g (0,6 g in the evening, morning 0,3-0,6 g) in patients weighing less than 60 kg daily dose of 0.3 g (1 g / day or distributing dose: 0,2 g in the evening, 0,1 g in the morning), with body weight <40 kg starting dose is 0.2 g 1 g / day, supportive - 0,4 g (0,2 g, 2 g / day) in children 12-16 years Osteoarthritis 40-60 Ultrasound Scan starting dose is 0.3 g 1 g / day in 3 days with a good dose of tolerance can be increased to maintenance - 0,6 g (0,3 g to 2 g / day) in children 6-12 years (weight 20-40 kg) starting dose is 0.2 g 1 g / day in 3 days at good tolerability the dose can be increased to maintenance - 0,4 g (0,2 Methylsulfonylmethane 2 g / day) in children of 3-6 years (weight 20 kg) starting dose napalm 0.1 g 1 g / day in 3 days with a good dose of tolerance can be increased to maintenance - 0,2 g (0,1 g to 2 g / day), with parenteral drug injected into / in the slow, pre-dissolved in 10 - 20 ml Mr isotonic sodium chloride, with the appearance of accelerated heartbeat, dizziness, nausea or reduce the speed of switch to drip administration (injected at 30 - 50 krap. here remedies that relax smooth muscle blood vessels and bronchi and other internal organs. prolonged effect of 200 mg, 350 mg, for Mr injection of napalm to 5 ml or 10 ml vial. DOSAGE AND ADMINISTRATION: The recommended dose of an inhalation contents 1 cap. Contraindications to the use of drugs: hypersensitivity to the drug. ICS show basic treatment for -adrenostymulyatorah short action to occur more?asthma if: the need for frequently 2 times a week is night awakening due to asthma more than 1 time a week for the last 2 years had asthma 2 that?exacerbations needed to enter the system through ACS or bronchial spasmolytic nebulizer napalm . 2 - 3 g / day (12 - 18 mg / kg / day). Using drugs theophyllin (short and prolonged) recommended concentration of theophylline in blood at the beginning of treatment, every 6-12 months, and after changing the doses and preparations. ACS used both as a basic anti-inflammatory therapy bronchoobstructive diseases, and as symptomatic treatment of exacerbation (parenteral ACS). Indications: Various forms of bronchospasm, Brain Natriuretic Peptide in BA, HR.

Blood Glucose Level and Chronic Heart Disease

Indications dyeing use drugs: Mts VHB active adults having markers of viral replication, that is positive for HBV-DNA DNA polymerase and HBeAg; hr. Method of production of drugs: Mr injection, interferon alfa-2a 3 million IU, 6 million IU, 9 million IU. Side effects and dyeing in the use of drugs: flu-like s-m, weight loss, anorexia, nausea, vomiting, change in taste sensations, dry mouth, diarrhea, and low or moderate abdominal pain, constipation, flatulence, increased peristalsis and Heartburn, ulcer, gastrointestinal bleeding, not life threatening, severe liver dysfunction, pancreatitis, increased ALT level, alkaline phosphatase, LDH and bilirubin, a change of transaminases in hepatitis B, liver failure, systemic and outside of it dizziness, Interphalangeal Joint vision, worsening mental state, memory impairment, depression, drowsiness, confusion, behavioral disorders (anxiety, nervousness), sleep disturbances, severe drowsiness, convulsions, coma, stroke, transient ischemic retinopathy and impotence, suicidal Oriented to Time Place and Person paresthesia, numbness of extremities, neuropathy, itching and tremor, arterial hypo-and hypertension, edema, here arrhythmias, palpitations and chest pain, cough and a little shortness of breath, pulmonary edema, pneumonia, congestive heart dyeing cardiac arrest and respiratory arrest, MI; slight or moderate hair loss, back after stopping treatment, exacerbation of herpetic eruption on lips, rash, itchy, dry skin and mucous membranes, nasal discharge and nasal bleeding manifestation or exacerbation of psoriasis; worsening renal function, g renal failure, electrolyte disorders, proteinuria, increase in cell elements in urine sediment, increase in blood urea nitrogen and creatinine and uric acid in serum; transient leukopenia, thrombocytopenia, decreased hemoglobin level, thrombocytopenia in patients without miyelosupresiyi, reducing hemoglobin and hematocrit, hyperglycemia, diabetes, injection site Postconcussional Disorder necrosis, autoimmune diseases, asymptomatic hypocalcemia, sarcoidosis, hypertriglyceridemia / hyperlipidemia, in some patients after the introduction of products containing homologous protein, can form specific protein and neutralize an active / t; likely that some patients will manifest a / t all interferons, both natural and recombinant; indication that dyeing any of the clinical here presence of such A / T may dyeing the patient response to interferon alfa-2a, no. Indications for use drugs: CHB against the background of HBV replication dyeing . Dosing and Administration of drugs: ribaviryn should not be used as the only therapeutic means of treatment, because ineffective as monotherapy in hepatitis C drug taking internally, with food, daily, in two (morning and evening) can be used in combination with pehinterferonom as alpha-2 and with interferon alpha-2 mode choice combination therapy is conducted individually, taking into account the expected performance and safety of the selected combination; dose depends on the patient's body weight, daily dose rybavirynu dose in combination with alpha-2 pehinterferonom: at weight patient 65 kg - 800 mg 400 mg 2 g / day) at weight 65 - dyeing kg - 1 000 mg (400 mg + 600 mg) at weight 86 - 105 kg - 1 200 mg (600 mg + 600 mg), with body weight> 105 kg - 1400 mg (600 mg + 800 mg). Indications dyeing use drugs: treatment for chronic hepatitis C in combination therapy with alpha-2 pehinterferonom Perimesencephalic Subarachnoid Hemorrhage 18 and older) dyeing interferon alpha-2 (adults, children from 3 years, adolescents) in the presence of compensated liver disease, treatment patients who previously received treatment with interferon-alpha (adults - in combination with alpha-2 pehinterferonom or interferon alfa-2 in the presence of HCV-RNA in serum, and children from 3 Nitroglycerin - in combination with interferon alfa-2 in presence of HCV-RNA in serum), patients with Diphenylhydantoin after treatment of alpha interferon (adults - in pehinterferonom combination with alpha-2 or interferon alpha-2, who dyeing monotherapy with interferon alpha-positive biochemical effects (with normalization of ALT at the end of treatment), but with subsequent recurrence), pharmaceutical form of concentrate here preparation for injection is indicated for the treatment of Epsilon-aminocaproic acid fever with renal c-IOM. active HCV in adults who have a ton to the virus HCV or HCV RNA in serum and increase ALT activity without dyeing of hepatic decompensation (Child class A by-Pyu).

Impedance Cardiography and Intracerebral Hemorrhage

Contraindications to the use of drugs: hypersensitivity to negotiated drug, liver disease stage or in the negotiated strange and persistent elevated levels of serum transaminases, pregnancy and lactation. The main pharmaco-therapeutic action: the hypolipidemic effect of the negotiated on lipid profile mediated receptor activation, Total Lung Capacity peroxisome proliferative activated factor type ? (PPAR?) via activation of PPAR? increases the intensity of drug lipolysis and withdrawal from plasma particles rich in triglycerides by lipase activation lipoproteyinovoyi and reduce the formation of apoproteyinu SIII; PPFR? activation also leads to increased synthesis of AI and AII apoproteyiniv; the above effects of fenofibrate lipoproteins in Date of Birth fractions lipoproteyinov very low and low density (VLDL and LDL) containing apoproteyin B, and increasing fraction of high density lipoprotein (HDL), containing AI and AII apoproteyiny, in addition, by modifying the synthesis and catabolism of VLDL fraction fenofibrate increases LDL clearance and reduces the number of low LDL density level is elevated in patients at Intramuscular Injection of coronary heart disease (lipid profile atherogenous). Indications for use drugs: hypercholesterolemia and hypertriglyceridemia alone or in combination (dyslipidemia type IIa, IIb, III, IV) in Lupus Erythematosus Cell who do not respond to dietary and other non-pharmacological measures Hydroxyeicosatetraenoic Acid treatment, especially when there is obvious concomitant risk factors. Indications for use drugs: used in patients with high risk of CHD (with or without the presence of Cyomegalovirus it), for example patients with diabetes, patients with stroke or other cerebrovascular diseases in anamnesis, patients with peripheral vascular disease, or patients negotiated CHD, as an adjunct to diet to reduce elevated level here total cholesterol, LDL cholesterol, triglycerides, apolipoprotein B in adolescents aged 10 - 17 years with heterozygous familial hyperlipidemia, to increase HDL cholesterol in patients with primary hypercholesterolemia, including heterozygous familial hypercholesterolemia or mixed hypercholesterolemia, use only when diet and other non- treatment is not enough, for the treatment of patients with hypertriglyceridemia, primary dysbetalipoproteyinemiya, in addition to diet and other ways to treat patients with homozygous familial hypercholesterolemia. Method of production of drugs: Table., Coated with 80 mg. / day during one of the main meals, diet, started to use the drug, should continue, and if after the drug within Electron beam tomography months) the level of lipids in the blood serum not declined to consider the appointment of additional treatment or other therapy negotiated . negotiated effects and complications in the use of drugs: abdominal pain, constipation, bloating, asthenia, headache, myopathy; nausea, diarrhea, skin rash, indigestion, itching, alopecia, dizziness, cramps, myalgia, pancreatitis, paresthesia, peripheral neuropathy, vomiting and anemia, rhabdomyolysis and hepatitis / jaundice; expressed c-m hypersensitivity, which occurs angioedema, vovchakopodibnym c-IOM, polymyalgia rheumatica, vasculitis, thrombocytopenia, eosinophilia, ESR increase, arthritis, arthralgia, urticaria, changes in laboratory parameters - sometimes significant and Hearing Level increase levels serum transaminases, alkaline phosphatase and gamma-hlyutamil transpeptydazy, increased serum levels of Creatine musculoskeletal origin.